Literature DB >> 21120538

Age-related stature and linear body segments in children with X-linked hypophosphatemic rickets.

Miroslav Zivičnjak1, Dirk Schnabel, Heiko Billing, Hagen Staude, Guido Filler, Uwe Querfeld, Marius Schumacher, Anke Pyper, Carmen Schröder, Jürgen Brämswig, Dieter Haffner.   

Abstract

Children with X-linked hypophosphatemic rickets (XLH) are prone to severe stunting. A multicenter mixed-longitudinal study was conducted to assess age-related stature, sitting height, arm and leg length in XLH patients on continuous treatment with phosphate and calcitriol. Mean standard deviation scores (SDS) for all body dimensions were markedly reduced and differed significantly among each other at the initial and subsequent evaluations (baseline: stature -2.48 SDS; sitting height -0.99 SDS; arm length -1.81 SDS; leg length -2.90 SDS; each p<0.001). A strong association between stature and leg length (r (2)=0.87, p<0.001) was noted. Leg length SDS decreased progressively during childhood (2-9 years) and adolescence (12-15 years; each p<0.001). Sitting height SDS increased significantly during late childhood, indicating uncoupled growth of the legs and trunk and resulting in an ever increasing sitting height index (i.e. ratio of sitting height to stature; age 2 years 2.0 SDS; age 10 years 3.3 SDS; p<0.001) that was associated with the degree of stunting (r (2)=0.314, p<0.001). Mean serum phosphate levels were positively associated with stature and leg length, but negatively with sitting height index. Based on these results, we can conclude that growth of the legs and trunk is uncoupled in XLH and related to serum phosphate levels.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21120538     DOI: 10.1007/s00467-010-1705-9

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  38 in total

1.  Developmental expression and tissue distribution of Phex protein: effect of the Hyp mutation and relationship to bone markers.

Authors:  A F Ruchon; H S Tenenhouse; M Marcinkiewicz; G Siegfried; J E Aubin; L DesGroseillers; P Crine; G Boileau
Journal:  J Bone Miner Res       Date:  2000-08       Impact factor: 6.741

Review 2.  Molecular pathogenesis of hypophosphatemic rickets.

Authors:  Suzanne M Jan de Beur; Michael A Levine
Journal:  J Clin Endocrinol Metab       Date:  2002-06       Impact factor: 5.958

3.  Vitamin-resistant rickets.

Authors:  H E PEDERSEN; H R McCARROLL
Journal:  J Bone Joint Surg Am       Date:  1951-01       Impact factor: 5.284

4.  Growth in X-linked hypophosphatemic rickets.

Authors:  Gema Ariceta; Craig B Langman
Journal:  Eur J Pediatr       Date:  2006-12-14       Impact factor: 3.183

5.  Gender-specific growth patterns for stature, sitting height and limbs length in Croatian children and youth (3 to 18 years of age).

Authors:  Miroslav Zivicnjak; Nina Smolej Narancić; Lajos Szirovicza; Doris Franke; Jasna Hrenović; Vesna Bisof
Journal:  Coll Antropol       Date:  2003-06

6.  Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis.

Authors:  Katherine Wesseling-Perry; Renata C Pereira; Hejing Wang; Robert M Elashoff; Shobha Sahney; Barbara Gales; Harald Jüppner; Isidro B Salusky
Journal:  J Clin Endocrinol Metab       Date:  2008-12-02       Impact factor: 5.958

7.  Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D-resistant rickets.

Authors:  F H Glorieux; P J Marie; J M Pettifor; E E Delvin
Journal:  N Engl J Med       Date:  1980-10-30       Impact factor: 91.245

8.  Calcium metabolism and growth during early treatment of children with X-linked hypophosphataemic rickets.

Authors:  K Kruse; G K Hinkel; B Griefahn
Journal:  Eur J Pediatr       Date:  1998-11       Impact factor: 3.183

9.  Nephrocalcinosis in X-linked hypophosphataemic rickets: its relationship to treatment, kidney function, and growth.

Authors:  S W Kooh; A Binet; A Daneman
Journal:  Clin Invest Med       Date:  1994-04       Impact factor: 0.825

10.  Calcimimetics as an adjuvant treatment for familial hypophosphatemic rickets.

Authors:  Uri S Alon; Rachel Levy-Olomucki; Wayne V Moore; Jason Stubbs; Shiguang Liu; L Darryl Quarles
Journal:  Clin J Am Soc Nephrol       Date:  2008-02-06       Impact factor: 8.237

View more
  22 in total

1.  Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial.

Authors:  Erik A Imel; Francis H Glorieux; Michael P Whyte; Craig F Munns; Leanne M Ward; Ola Nilsson; Jill H Simmons; Raja Padidela; Noriyuki Namba; Hae Il Cheong; Pisit Pitukcheewanont; Etienne Sochett; Wolfgang Högler; Koji Muroya; Hiroyuki Tanaka; Gary S Gottesman; Andrew Biggin; Farzana Perwad; Meng Mao; Chao-Yin Chen; Alison Skrinar; Javier San Martin; Anthony A Portale
Journal:  Lancet       Date:  2019-05-16       Impact factor: 79.321

Review 2.  X-linked hypophosphatemia and growth.

Authors:  R Fuente; H Gil-Peña; D Claramunt-Taberner; O Hernández; A Fernández-Iglesias; L Alonso-Durán; E Rodríguez-Rubio; F Santos
Journal:  Rev Endocr Metab Disord       Date:  2017-03       Impact factor: 6.514

3.  Kidney transplantation fails to provide adequate growth in children with chronic kidney disease born small for gestational age.

Authors:  Doris Franke; Rena Steffens; Lena Thomas; Leo Pavičić; Thurid Ahlenstiel; Lars Pape; Jutta Gellermann; Dominik Müller; Uwe Querfeld; Dieter Haffner; Miroslav Živičnjak
Journal:  Pediatr Nephrol       Date:  2016-10-21       Impact factor: 3.714

Review 4.  The changing face of hypophosphatemic disorders in the FGF-23 era.

Authors:  Janet Y Lee; Erik A Imel
Journal:  Pediatr Endocrinol Rev       Date:  2013-06

Review 5.  FGF23 and Associated Disorders of Phosphate Wasting.

Authors:  Anisha Gohil; Erik A Imel
Journal:  Pediatr Endocrinol Rev       Date:  2019-09

6.  Patterns of growth after kidney transplantation among children with ESRD.

Authors:  Doris Franke; Lena Thomas; Rena Steffens; Leo Pavičić; Jutta Gellermann; Kerstin Froede; Uwe Querfeld; Dieter Haffner; Miroslav Živičnjak
Journal:  Clin J Am Soc Nephrol       Date:  2014-10-28       Impact factor: 8.237

7.  High bone mineral apparent density in children with X-linked hypophosphatemia.

Authors:  S S Beck-Nielsen; K Brixen; J Gram; C Mølgaard
Journal:  Osteoporos Int       Date:  2013-02-07       Impact factor: 4.507

8.  Results of deformity correction in children with X-linked hereditary hypophosphatemic rickets by external fixation or combined technique.

Authors:  Arnold Popkov; Anna Aranovich; Dmitry Popkov
Journal:  Int Orthop       Date:  2015-07-07       Impact factor: 3.075

9.  Effects of growth hormone treatment on adult height in severely short children with X-linked hypophosphatemic rickets.

Authors:  Nadine Meyerhoff; Dieter Haffner; Hagen Staude; Elke Wühl; Michaela Marx; Rolf Beetz; Uwe Querfeld; Martin Holder; Heiko Billing; Wolfgang Rabl; Carmen Schröder; Olaf Hiort; Jürgen H Brämswig; Annette Richter-Unruh; Dirk Schnabel; Miroslav Živičnjak
Journal:  Pediatr Nephrol       Date:  2017-10-20       Impact factor: 3.714

Review 10.  Hypophosphatemia and growth.

Authors:  Fernando Santos; Rocío Fuente; Natalia Mejia; Laura Mantecon; Helena Gil-Peña; Flor A Ordoñez
Journal:  Pediatr Nephrol       Date:  2012-11-22       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.